💫Visit our booth:
The world’s leading cancer research minds will converge at the ESMO Congress 2023. We are thrilled to announce that Nanolive will be exhibiting there from October 20 to 23, at Booth #560 in Hall 5!
Come and meet our team and discover the revolutionary world of label-free live cell imaging and our latest innovations.
Our CEO, Yann Cotte, will also be on-site and ready to engage in exclusive discussions, gaining profound insights into the future of live cell imaging in cancer research.
We are looking forward to meeting with all of you!
Read our latest news
Simplifying drug delivery assessment: Industry perspectives
Optimization of drug delivery systems can become slow, resource intensive, and reliant on incomplete information. With one assay, Nanolive monitors the complete dynamics of drug delivery, reducing phototoxicity from labels and helping teams identify where delivery succeeds or fails.
Webinar – Investigating nanoparticle delivery with label-free live cell imaging
Watch our latest webinar, where Elizabeth Nelson shares research performed at the MIT Koch Institute for Integrative Cancer Research, demonstrating a live-cell imaging workflow to quantify the dynamic uptake of nanoparticles…
Move beyond endpoints with dynamic EC50
Discover case study data for a dynamic approach to monitoring EC50 to gain more accurate insights into drug function.